Although literature is scarce, the reduction of GLUT-4, GLUT-3 and IRS-1 expression in GDM patients could be correlated with a lower SHBG activity, which could favor insulin resistance (Zhang et al., 2016). The gene discussed is IRS1; the disease is Insulin resistance.